We show that B1.23.2, engineered to eliminate potential complications due to Fc receptor interactions, stimulates proliferation and activation of human PBMC-derived NK cells in culture and can lead to control of tumor growth in NSG-IL15 mice. The gene discussed is IL15; the disease is neoplasm.